Compounds > sorafenib
Page last updated: 2024-09-05

sorafenib and nu6102

sorafenib has been researched along with nu6102 in 1 studies

Compound Research Comparison

Studies
(sorafenib)		Trials
(sorafenib)		Recent Studies (post-2010)
(sorafenib)		Studies
(nu6102)		Trials
(nu6102)		Recent Studies (post-2010) (nu6102)
6,5207305,25132022

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)nu6102 (IC50)
Serine/threonine-protein kinase Chk1Homo sapiens (human)0.5
Cyclin-T1Homo sapiens (human)2.585
Rho-associated protein kinase 2Homo sapiens (human)0.6
G2/mitotic-specific cyclin-B2Homo sapiens (human)0.0095
Cyclin-dependent kinase 1Homo sapiens (human)0.097
Cytochrome P450 3A4Homo sapiens (human)0.006
Cyclin-dependent kinase 4Homo sapiens (human)0.4087
G2/mitotic-specific cyclin-B1Homo sapiens (human)0.1329
G2/mitotic-specific cyclin-BMarthasterias glacialis (spiny starfish)0.0074
Cyclin-A2Homo sapiens (human)0.1303
G1/S-specific cyclin-D1Homo sapiens (human)0.2598
G1/S-specific cyclin-E1Homo sapiens (human)0.0335
Cyclin-dependent kinase 2Homo sapiens (human)0.1041
Prostaglandin G/H synthase 2Homo sapiens (human)0.0081
Glycogen synthase kinase-3 betaHomo sapiens (human)0.04
Cyclin-dependent kinase 7Homo sapiens (human)3.7667
Cyclin-dependent kinase 9Homo sapiens (human)2.09
Cyclin-HHomo sapiens (human)3.45
CDK-activating kinase assembly factor MAT1Homo sapiens (human)2.5
Cyclin-A1Homo sapiens (human)0.0054
Cyclin-dependent-like kinase 5 Homo sapiens (human)0.2985
Dual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)0.9
Cyclin-dependent kinase 5 activator 1Homo sapiens (human)0.117
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrialHomo sapiens (human)0.8
G2/mitotic-specific cyclin-B3Homo sapiens (human)0.0095
Cyclin-dependent kinase 1Oryzias latipes (Japanese medaka)0.0074

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheng, W; Kan, Q; Li, Y; Tian, X; Wang, S; Wei, H; Yang, Z1

Reviews

1 review(s) available for sorafenib and nu6102

ArticleYear
Recent development of CDK inhibitors: An overview of CDK/inhibitor co-crystal structures.
    European journal of medicinal chemistry, 2019, Feb-15, Volume: 164

    Topics: Animals; Crystallography, X-Ray; Cyclin-Dependent Kinases; Humans; Molecular Structure; Protein Binding; Protein Kinase Inhibitors

2019